RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
M. Gagne, B. J. Flynn, C. C. Honeycutt…·D. C. Douek
RBD-62, a high-affinity ACE2 antagonist, limits SARS-CoV-2 replication in both upper and lower airways in rhesus macaques without blocking memory responses or causing anti-drug immunity.